-
Uncategorized2 days ago
T-Cell Synapse Formation Is Restrained by PTPN22–PSTPIP1 Signaling
T cells don’t simply switch on—they reshape themselves. When these immune sentinels recognize a target, they rapidly reorganize their internal scaffolding to build an immunological synapse,...
-
Uncategorized2 days ago
Biotech’s coming of age
Nature Biotechnology, Published online: 10 June 2026; doi:10.1038/s41587-026-03179-0 Biotech is back. But continued investor caution, the rise of China and fast-moving AI are changing the sector’s...
-
Uncategorized2 days agoSTAT+: The shortage of many medicines in the U.S. remains a ‘systemic’ problem, a new analysis finds
The number of prescription drug shortages in the U.S. fell by 23% last year, marking the second consecutive year of declines and the lowest level since...
-
Uncategorized2 days ago
Hikma outlines plan to invest $267M in Ohio plants, creating 350 jobs
Hikma outlines plan to invest $267M in Ohio plants, creating 350 jobs
-
Uncategorized2 days ago
First-in-Human Trial Reports Promising Dual Lassa–Rabies Vaccine Data
Researchers at the University of Maryland School of Medicine’s Center for Vaccine Development and Global Health (CVD) reported encouraging interim results from an early clinical trial...
-
Uncategorized2 days ago
Incyte to Acquire Vega Therapeutics for Up-to-$2B, Growing Hematology Pipeline with Phase III VWD Candidate
Incyte has agreed to acquire Vega Therapeutics for up to $2 billion, the companies said, in a deal designed to bolster the buyer’s hematology pipeline with...
-
Uncategorized2 days agoDiabetes Association in uproar after members expelled from annual meeting over protest of NIH cuts
It didn’t have to be this way. The condemnations keep coming four days after security officers escorted five diabetes experts out of the American Diabetes Association...
-
Uncategorized2 days agoMerck, Gilead report mixed outcomes in key lung cancer, HIV studies
Trodelvy’s latest setback carries implications for a newly important Merck drug, while the success of a once-weekly HIV tablet could boost Gilead’s main business.
-
Uncategorized2 days ago
From executive assistant to chief executive: Charles River CEO Birgit Girshick on ‘the next big transition’ in the CRO industry
When Charles River Laboratories CEO Birgit Girshick started her career as an executive assistant with the company in Germany in 1989, she didn’t know what was...
-
Uncategorized2 days agoTrump administration warns more than 500 hospitals to provide more price information or face fines
WASHINGTON — The Trump administration has warned more than 500 hospitals that they are failing to provide the public with basic pricing information — arguing that the lack...
An obesity drug deep-dive, and peptides move mainstream
RFK Jr. claims his calendar is publicly available. We’ve been trying to get it for a year
